ARGUS II RETINAL PROSTHESIS 011014-003-K 011014

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,s report with the FDA on 2017-03-09 for ARGUS II RETINAL PROSTHESIS 011014-003-K 011014 manufactured by Second Sight Medical Products, Inc..

Event Text Entries

[69522679] All pertinent information available to second sight medical products, inc. Has been submitted. The company is submitting this mdr to ensure full compliance with 21 cfr part 803.
Patient Sequence No: 1, Text Type: N, H10


[69522680] This patient was implanted with an argus ii device on (b)(6) 2016. This patient was diagnosed with hypotony in the implanted eye on (b)(6) 2016. On (b)(6) 2017, the patient underwent revision surgery during which intravitreal and anterior chamber healon? Injections were administered in the implanted eye. On (b)(6) 2017, intraocular pressure in the patient's implanted eye was still low. There was no defect or malfunction of the device associated with this event.
Patient Sequence No: 1, Text Type: D, B5


[109697483] This event represents a follow-up report to mdr# 3004081696-2017-00004. All pertinent information available to second sight medical products, inc. Has been submitted. The company is submitting this mdr to ensure full compliance with 21 cfr part 803.
Patient Sequence No: 1, Text Type: N, H10


[109697484] This patient underwent revision surgery on (b)(6) 2017 to address ongoing hypotony. On (b)(6) 2017, this patient was diagnosed with phthisis bulbi following post-operative hypotony and was prescribed analgesics due to ongoing pain. New information: on (b)(6) 2018, a decision was made to explant the device due to ongoing pain and phthisis. On (b)(6) 2018, the extraocular portion of the argus ii device was removed and the electrode array was left tacked to the retina. On (b)(6) 2018, the surgeon reported that the patient was doing fine after explant surgery and was discharged from the hospital. Patient's pain had reduced and intraocular pressure in the explanted eye was 4 mmhg. There was no defect or malfunction of the device associated with this event.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3004081696-2017-00004
MDR Report Key6392906
Report SourceFOREIGN,HEALTH PROFESSIONAL,S
Date Received2017-03-09
Date of Report2017-02-09
Date of Event2017-02-09
Date Mfgr Received2017-02-09
Device Manufacturer Date2015-02-15
Date Added to Maude2017-03-09
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. MARK LOAR
Manufacturer Street12744 SAN FERNANDO RD. SUITE 400
Manufacturer CitySYLMAR CA 91342
Manufacturer CountryUS
Manufacturer Postal91342
Manufacturer Phone8188335049
Manufacturer G1SECOND SIGHT MEDICAL PRODUCTS, INC.
Manufacturer Street12744 SAN FERNANDO RD. SUITE 400
Manufacturer CitySYLMAR CA 91342
Manufacturer CountryUS
Manufacturer Postal Code91342
Single Use3
Previous Use Code3
Removal Correction NumberN/A
Event Type3
Type of Report3

Device Details

Brand NameARGUS II RETINAL PROSTHESIS
Generic NameRETINAL PROSTHESIS
Product CodeNBF
Date Received2017-03-09
Model Number011014-003-K
Catalog Number011014
Lot NumberN/A
Device Expiration Date2017-02-15
OperatorPHYSICIAN
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerSECOND SIGHT MEDICAL PRODUCTS, INC.
Manufacturer Address12744 SAN FERNANDO RD. SUITE 400 SYLMAR CA 91342 US 91342


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention; 3. Deathisabilit 2017-03-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.